Sage Mountain Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-323
| Closed | -$205K | – | 539 |
|
|
2025
Q1 | $205K | Sell |
323
-101
| -24% | -$64.1K | 0.02% | 373 |
|
|
2024
Q4 | $302K | Buy |
424
+14
| +3% | +$9.98K | 0.02% | 294 |
|
|
2024
Q3 | $431K | Buy |
410
+34
| +9% | +$35.8K | 0.04% | 224 |
|
|
2024
Q2 | $396K | Buy |
376
+72
| +24% | +$75.8K | 0.04% | 208 |
|
|
2024
Q1 | $293K | Buy |
304
+36
| +13% | +$34.7K | 0.03% | 244 |
|
|
2023
Q4 | $235K | Sell |
268
-4
| -1% | -$3.51K | 0.03% | 236 |
|
|
2023
Q3 | $224K | Buy |
+272
| New | +$224K | 0.03% | 228 |
|